biped.ai Device Gains Public Reimbursement in France

01.04.2025

biped.ai, a Serpentine Ventures portfolio company, reached a major milestone as its customer obtained official reimbursement approval from MDPH France for its NOA mobility device, enhancing accessibility to innovative mobility solutions.

biped.ai, a Serpentine Ventures portfolio company, reached a major milestone as its customer obtained official reimbursement approval from MDPH France for its NOA mobility device, enhancing accessibility to innovative mobility solutions.

Similar Articles

04.11.2025

RAAAM Raises USD 17.5M Series A Led by NXP Semiconductors

03.09.2025

Voltiris Ranks 4th at the 2025 TOP 100 Swiss Startup Awards

20.08.2025

Luna Diabetes Closes Series A to Transform Nighttime Glucose Control

18.08.2025

evulpo closes CHF 8.8M Series A

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

Your cookie preferences have been saved.